Darunavir/ritonavir
Transcript of Darunavir/ritonavir
Reactions 1457 - 22 Jun 2013
★ SDarunavir/ritonavir
Acute demyelinating polyneuropathy (first report) inan elderly patient: case report
A 65-year-old HIV-infected man developed acutedemyelinating polyneuropathy during treatment withdarunavir and ritonavir.
The man presented with muscle ache and progressiveweakness of his lower limbs; he was totally wheelchair-bound.Darunavir 600mg and ritonavir 100mg twice daily [routes notstated] had been added to his antiretroviral backbone regimenof didanosine and abacavir 3 months earlier, in February 2007.Electromyogram results revealed severe sensory peripheralpolyneuropathy.
All the man’s medication was withdrawn. His clinical staterapidly deteriorated, and his CD4+ cell count fell. He wastreated with empirical antiretrovirals including raltegravir,etravirine and emtricitabine/tenofovir disoproxil fumarate.Three months later, his electromyogram results revealed anormal pattern, with no signs of peripheral neuropathy ormyopathy.
Author comment: "In this report, we present a case ofsevere HIV-1-related acute demyelinating polyneuropathywhich initiated after new generation PI [protease inhibitor]darunavir/ritonavir was given and resolved after cessation ofthe drug without the use of immune-based therapies . . . TheHIV-related inflammatory neuropathies can be furtherdistinguished into a subtype associated with HIV infection perse and an antiretroviral (ARV) toxic neuropathy associatedwith the use of ARV agents."Lorber M. A case of possible darunavir/ritonavir-induced peripheral neuropathy:Case description and review of the literature. Journal of the InternationalAssociation of Providers of AIDS Care 12: 162-165, No. 3, May-Jun 2013.Available from: URL: http://dx.doi.org/10.1177/2325957412471993 -Israel 803088536
» Editorial comment: A search of AdisBase, Medline andEmbase did not reveal any previous case reports ofpolyneuropathy associated with darunavir. The WHO ADRdatabase contained 1 report of polyneuropathy associated withdarunavir.
1
Reactions 22 Jun 2013 No. 14570114-9954/10/1457-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved